New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL Novolog Mix 70/30 Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…

The post New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog